Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation.
To date, apoptosis has been characterized biochemically by the production of 180-200 bp internucleosomal DNA fragments resulting from the activation of an endonuclease(s). The principal morphological feature of apoptosis is the condensation of chromatin and it has been assumed that this may reflect the oligonucleosomal fragmentation pattern. We have re-examined this dogma by comparing the biochemical and morphological features of cell death in several epithelial cell types (HT-29-I1 colon adenocarcinoma, CC164 mink lung, DU-145 human prostatic carcinoma and MCF-7 human breast adenocarcinoma) and one mesenchymal cell line (H11ras-R3 ras-transformed rat fibroblasts). Cell death was induced either by serum deprivation, TGF-beta 1 or etoposide, or by leaving cells to reach confluence. Cell death was assessed with respect to detachment from monolayers, morphological changes and DNA integrity. The DNA-binding fluorophore Hoechst 33258 revealed chromatin condensation patterns consistent with apoptotic cell death in all cell types except MCF-7 cells. Using field inversion gel electrophoresis in conjunction with conventional 2% agarose gel electrophoresis, cleavage of DNA to 50 kbp fragments was observed in all cases except MCF-7 cells. This preceded the appearance of oligonucleosomal fragments in HT-29-I1, CC164 and H11ras-R3 cells. Although the DNA of DU-145 cells fragmented into 50 kbp units, and although the cells exhibited classical apoptotic morphology, no subsequent internucleosomal cleavage was observed. These results suggest that changes in the integrity of DNA indicative of the release of chromatin loop domains occur before cleavage at internucleosomal sites is initiated and that the latter is not an essential step in the apoptotic process.
Oberhammer
F
F
Institute for Tumour Biology, University of Vienna, Austria.
Wilson
J W
JW
Dive
C
C
Morris
I D
ID
Hickman
J A
JA
Wakeling
A E
AE
Walker
P R
PR
Sikorska
M
M
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D001943:Breast Neoplasms; D002460:Cell Line; D002461:Cell Line, Transformed; D004247:DNA / Q000378:metabolism*; D004273:DNA, Neoplasm / Q000378:metabolism*; D004847:Epithelial Cells; D005047:Etoposide / Q000633:toxicity*; D005260:Female; D011905:Genes, ras; D006801:Humans; D008297:Male; D009707:Nucleosomes / Q000378:metabolism / Q000648:ultrastructure*; D011471:Prostatic Neoplasms; D051381:Rats; D011994:Recombinant Proteins / Q000633:toxicity; D016212:Transforming Growth Factor beta / Q000633:toxicity; D014407:Tumor Cells, Cultured
D004273:DNA, Neoplasm; D009707:Nucleosomes; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D005047:Etoposide; D004247:DNA